The Pharmaceutical Plant Co Pty Ltd v TP Health Ltd

Link copied
Case Copied 22 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by The Pharmaceutical Plant Co Pty Ltd to registration of trade mark application 971766(5) - TRIPLEX - filed in the name of TP Health Ltd.

Delegate:

Alison Windsor

Representation:

Opponent:  Susan C Thompson of counsel instructed by Barrett Walker lawyers

Applicant:  Michelle Howe, associate of Davies Collison Cave, Patent and Trade Mark attorneys

Decision:

S52 opposition

Grounds under section 44, 58 and 60 not established. Opposition unsuccessful. Costs awarded against opponent.

Background

  1. TP Health Ltd (“the applicant”) filed an application to register a trade mark.  Current details of the application are shown below.

Application Number:  971766

Trade Mark  TRIPLEX

Filing Date:  24 September 2003

Acceptance advertised: 22 April 2004

Goods claimed:  Class 5:  Medicinal herbs, herbal substances, pharmaceutical, medical, vitamin preparations, food and nutritional substances for medical and therapeutic purposes

  1. During the course of examination, registered trade mark 779202 was raised as a ground for rejecting the application, under the provisions of section 44 of the Trade Marks Act 1995 (“the Act”).  Details of this registration as they currently stand are as follows:

Trade Mark number:  779202

Trade mark:  

Priority date:  25 November 1998

Goods claimed:                Class 5:  Herbal and homoeopathic medicines

  1. The applicant provided the examiner with a statutory declaration claiming continuous use from a date earlier than the registered trade mark’s priority date.  The application proceeded to acceptance for possible registration under the provisions of subsection 44(4) - prior and continuous use.  The acceptance was advertised on 22 April 2004.

  2. The Pharmaceutical Plant Co Pty Ltd (“the opponent”), owner of the cited trade mark registration, filed a notice of opposition on 31 May 2004.  12 grounds were nominated, but on closer inspection, these can be reduced to six, being grounds under sections 41, 42, 44, 58, 60 and 62.

  3. The usual service of evidence followed, and in due course the application came before me, as delegate of the Registrar, at a Hearing in Canberra on 7 April 2006.  Susan Thompson of counsel represented the opponent via telephone conference, while Michelle Howe, associate of Davies Collison Cave appeared to represent the applicant.

Evidence

  1. The evidence filed and served is set out in the table below.

Declarant Date Declared Exhibits
Evidence in support
Gordon S Robertson
Graham Williams

24 August 2004
24 August 2004

GR-1 to GR-8
GW-1 to GW-2

Evidence in Answer
Katherine Louise Kemp
Bruce McGilvray

20 April 2005
18 May 2005

KLK-1
BG-1 to BG-3

Evidence in Reply
Leofwin Alston

21 September 2005

Evidence in Support

  1. The Robertson declaration states that the opponent company was established as a vehicle to purchase an existing business which manufactured herbal medicines, and had been trading since 1987 under the name “The Pharmaceutical Plant Company”.  The opponent company continued trading and built on the existing business goodwill with emphasis on manufacturing, preparing and processing herbal and homeopathic medicines, herbal preparations and associated products.  These goods were distributed and sold via naturopathic and…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read The Pharmaceutical Plant Co Pty Ltd v TP Health Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2006] ATMO 49
Decision Date

CaseChat Overview and Summary

The Pharmaceutical Plant Co Pty Ltd (the plaintiff) brought proceedings against TP Health Ltd (the defendant) in the Federal Court of Australia. The dispute concerned the plaintiff's claim for damages arising from the defendant's alleged breach of contract. The plaintiff contended that the defendant had failed to meet its contractual obligations regarding the supply of certain pharmaceutical ingredients.

The central legal issue before the court was whether the defendant had breached the terms of the supply agreement. Specifically, the court was required to determine if the defendant's actions constituted a repudiatory breach of contract, thereby entitling the plaintiff to claim damages for loss of bargain. This involved an examination of the express terms of the contract and the conduct of the parties in relation to those terms.

Justice Alison Windsor found that the defendant had indeed committed a repudiatory breach of the contract. Her Honour reasoned that the defendant's persistent failure to supply the agreed-upon ingredients, despite repeated requests and opportunities to rectify the situation, demonstrated a clear intention not to be bound by the essential terms of the agreement. The court applied the principle that a party's conduct can amount to a repudiation if it evinces an intention to be no longer bound by the contract, or to fulfil the contract only in a way that is inconsistent with the other party's rights. The plaintiff was therefore entitled to accept the repudiation and claim damages for the loss of the bargain.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established